Literature DB >> 7087521

Esophageal replacement with jejunum in children: an 18 to 33 year follow-up.

W S Ring, R L Varco, P R L'Heureux, J E Foker.   

Abstract

Since 1947 a total of 32 staged jejunal interpositions have been performed in children for total esophageal replacement. There have been no failures of the jejunum to reach the neck, no loss of graft, and no deaths. The first 16 of these 32 children have now reached adulthood and form the basis for this report on the late functional results of staged jejunal interposition. Among these 16 patients there occurred four cervical fistulas which healed without sequelae (25%), one cervical stricture which necessitated dilatation but not revision (6%), one early cervical revision for necrosis of the distal tip of the graft (6%), and no complications related to the distal anastomosis. Long-term follow-up (range 18 to 33 years; mean 27 years) was obtained in 100% (16/16) of patients. A barium swallow was obtained in 81% (13/16) at a mean of 25 years following initial reconstruction (range 14 to 33 years). The fact that all patients could eat a regular diet at normal speeds indicates satisfactory long-term function. Two patients (13%) reported mild cervical dysphagia. A barium swallow in one of these patients revealed no abnormalities. The other was found to have an apparent esophageal diverticulum which resulted because the jejunum was end-to-side to the esophagus. This was recently corrected 27 years after the initial reconstruction and represented the only late complication of the procedure. There were no late strictures or peptic ulcerations. Motility of the jejunal limb was normal in 12 of the 13 patients studied. These results demonstrate that staged jejunal interposition can be accomplished reliably and safely in children with excellent long-term functional results and a minimum of late complications. The jejunum should be considered as an alternative to colon and gastric tubes for total esophageal replacement in children.

Entities:  

Mesh:

Year:  1982        PMID: 7087521

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  17 in total

1.  Oesophageal substitution by jejunal free graft: follow-up data and an evaluation.

Authors:  R D Spicer; E L Cusick
Journal:  Pediatr Surg Int       Date:  1996-04       Impact factor: 1.827

Review 2.  Surgical techniques for esophageal replacement in children.

Authors:  Shilpa Sharma; Devendra K Gupta
Journal:  Pediatr Surg Int       Date:  2017-01-06       Impact factor: 1.827

3.  Long-gap oesophageal atresia.

Authors:  L Spitz; E M Kiely; D P Drake; A Pierro
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

4.  Oesophageal substitution with free and pedicled jejunum: short- and long-term outcomes.

Authors:  J A Cauchi; R G Buick; P Gornall; M H Simms; D H Parikh
Journal:  Pediatr Surg Int       Date:  2006-09-22       Impact factor: 1.827

5.  Caustic ingestion.

Authors:  L Spitz; K Lakhoo
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

6.  Roux-en-Y.

Authors:  R M Kirk
Journal:  World J Surg       Date:  1985-12       Impact factor: 3.352

7.  Corrosive esophagitis in children.

Authors:  Yu-Chih Huang; Yen-Hsuan Ni; Hong-Shiee Lai; Mei-Hwei Chang
Journal:  Pediatr Surg Int       Date:  2004-04-09       Impact factor: 1.827

Review 8.  Oesophageal replacement in children.

Authors:  G S Arul; D Parikh
Journal:  Ann R Coll Surg Engl       Date:  2008-01       Impact factor: 1.891

9.  Esophageal replacement in children by an isoperistaltic gastric tube: a 12-year experience.

Authors:  J Borgnon; P Tounian; F Auber; M Larroquet; F Boeris Clemen; J P Girardet; G Audry
Journal:  Pediatr Surg Int       Date:  2004-07-09       Impact factor: 1.827

10.  Repair of long-gap esophageal atresia: gastric conduits may improve outcome-a 20-year single center experience.

Authors:  Catherine J Hunter; Mikael Petrosyan; Meghan E Connelly; Henri R Ford; Nam X Nguyen
Journal:  Pediatr Surg Int       Date:  2009-12       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.